For the quarter ending 2026-03-31, BCRX has $465,052K in assets. $1,018,895K in debts. $171,591K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 171,591 | 89,736 | 84,078 | 88,033 |
| Restricted cash | 854 | 201 | 579 | 492 |
| Short-term investments | 66,809 | 185,011 | 128,795 | 172,005 |
| Trade receivables | 109,272 | 106,818 | 91,325 | 91,177 |
| Inventory, net | 5,985 | 5,398 | 5,232 | 5,044 |
| Prepaid expenses and other current assets | 19,114 | 17,182 | 16,502 | 12,541 |
| Current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations | - | - | 29,173 | 29,170 |
| Total current assets | 373,625 | 404,346 | 355,684 | 398,462 |
| Long-term inventory, net | 28,176 | 23,990 | 23,390 | 22,205 |
| Property and equipment, net | 9,368 | 8,783 | 8,396 | 8,457 |
| Long-term investments | 20,569 | 61,164 | 39,669 | 10,101 |
| Right of use assets, net | 13,617 | 10,203 | 10,840 | 11,546 |
| Other assets | 19,697 | 5,672 | 4,387 | 3,592 |
| Non-current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations | - | - | 4,058 | 2,825 |
| Total assets | 465,052 | 514,158 | 446,424 | 457,188 |
| Accounts payable | 10,958 | 15,826 | 5,567 | 8,589 |
| Accrued expenses | 119,398 | 126,413 | 118,778 | 107,114 |
| Share-based liability | 16,216 | 13,743 | - | - |
| Operating lease liabilities | 1,858 | 317 | 348 | 392 |
| Finance lease liabilities | 1,235 | 1,312 | 1,435 | 1,616 |
| Royalty financing obligations | 40,317 | 38,455 | 37,686 | 35,741 |
| Current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations | - | - | 26,423 | 23,708 |
| Deferred revenue | 5,409 | - | - | - |
| Total current liabilities | 195,391 | 196,066 | 190,237 | 177,160 |
| Operating lease liabilities | 11,122 | 8,571 | 8,425 | 8,489 |
| Finance lease liabilities | 1,173 | 1,441 | 1,742 | 2,043 |
| Royalty financing obligations | 407,181 | 427,233 | 439,107 | 447,842 |
| Secured term loan | 395,197 | 0 | 194,366 | 242,794 |
| Non-current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations | - | - | 436 | 454 |
| Deferred revenue | 8,831 | - | - | - |
| Total liabilities | 1,018,895 | 633,311 | 834,313 | 878,782 |
| Common stock, 0.01 par value shares authorized - 450,000 shares issued and outstanding 254,014 at march31, 2026 and 213,060 at december31, 2025 | 2,540 | 2,131 | 2,105 | 2,099 |
| Additional paid-in capital | 1,671,976 | 1,384,857 | 1,360,890 | 1,339,584 |
| Accumulated other comprehensive (loss) income | -368 | 38 | 1,140 | 1,646 |
| Accumulated deficit | -2,227,991 | -1,506,179 | -1,752,024 | -1,764,923 |
| Total stockholders deficit | -553,843 | -119,153 | -387,889 | -421,594 |
| Total liabilities and stockholders deficit | 465,052 | 514,158 | 446,424 | 457,188 |
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)